BRVE
Braveheart Bio, Inc.
21.30$
-0.7%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Cash Flow
Braveheart Bio, Inc. (BRVE) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Operating Cash Flow" came in at -17 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q1 25 | Q2 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|
| 0.0 | 0.0 | -5.2 | -17 | |
| 0.0 | 0.0 | 0.0 | 0.0 | |
| 0.0 | 0.0 | 1.8 | 1.1 | |
| 0.0 | 0.0 | 7.3 | -3.1 | |
| 0.0 | 0.0 | 3.0 | 0.0 | |
| 0.0 | 0.0 | -0.4 | 59 | |
| 0.0 | 0.0 | -8.6 | 42 | |
| 0.0 | 0.0 | -8.2 | -17 |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.